These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25546321)

  • 1. Failure of omalizumab in the treatment of solar urticaria.
    Müller S; Schempp CM; Jakob T
    J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):524-5. PubMed ID: 25546321
    [No Abstract]   [Full Text] [Related]  

  • 2. Omalizumab in chronic spontaneous urticaria: A real-life experience of dose and intervals adjustments in Belgium.
    de Montjoye L; Herman A; Dumoutier L; Lambert M; Tromme I; Baeck M
    Ann Allergy Asthma Immunol; 2018 Nov; 121(5):620-622. PubMed ID: 30392532
    [No Abstract]   [Full Text] [Related]  

  • 3. Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria.
    Curto-Barredo L; Spertino J; Figueras-Nart I; Expósito-Serrano V; Guilabert A; Melé-Ninot G; Cubiró X; Bonfill-Ortí M; Garcias-Ladaria J; Villar M; García-Navarro X; Bielsa-Marsol I; Vilavella M; Aparicio G; Baliu-Piqué C; Álvarez A; Lamas-Domenech N; Duran-Jordà X; Serra-Baldrich E; Giménez-Arnau A
    Br J Dermatol; 2018 Jul; 179(1):210-212. PubMed ID: 29368377
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of omalizumab dosing and frequency in chronic idiopathic urticaria: Retrospective chart review.
    Clark JJ; Secrest AM; Hull CM; Eliason MJ; Leiferman KM; Gleich GJ; Powell DL
    J Am Acad Dermatol; 2016 Jun; 74(6):1274-6. PubMed ID: 27185439
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of omalizumab 150 mg/month as a maintenance dose in patients with severe chronic spontaneous urticaria showing a prompt and complete response to the drug.
    Asero R
    Allergy; 2018 Nov; 73(11):2242-2244. PubMed ID: 29989179
    [No Abstract]   [Full Text] [Related]  

  • 6. Effectiveness and safety of omalizumab in chronic spontaneous or inducible urticaria: evaluation of 154 patients.
    Ghazanfar MN; Sand C; Thomsen SF
    Br J Dermatol; 2016 Aug; 175(2):404-6. PubMed ID: 26972689
    [No Abstract]   [Full Text] [Related]  

  • 7. [Partial response of solar urticaria to omalizumab therapy].
    Kowalzick L; Thiel W; C Bielfeld ; Ziegler H; Eickenscheidt L
    Hautarzt; 2017 Jun; 68(6):492-496. PubMed ID: 27995273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized omalizumab treatment improves clinical benefit in patients with chronic spontaneous urticaria.
    Niemeyer-van der Kolk T; van Maaren MS; van Doorn MBA
    J Allergy Clin Immunol; 2018 Dec; 142(6):1992-1994. PubMed ID: 30144475
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful omalizumab treatment in chronic spontaneous urticaria is associated with lowering of serum IL-31 levels.
    Altrichter S; Hawro T; Hänel K; Czaja K; Lüscher B; Maurer M; Church MK; Baron JM
    J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):454-5. PubMed ID: 25371135
    [No Abstract]   [Full Text] [Related]  

  • 10. Cholinergic urticaria with hypohidrosis successfully treated with omalizumab.
    Ihibashi-Kunimi Y; Imafuku S
    J Dermatol; 2020 Feb; 47(2):e47-e48. PubMed ID: 31663149
    [No Abstract]   [Full Text] [Related]  

  • 11. Omalizumab for the Treatment of Chronic Idiopathic Urticaria: Systematic Review of the Literature.
    Tonacci A; Billeci L; Pioggia G; Navarra M; Gangemi S
    Pharmacotherapy; 2017 Apr; 37(4):464-480. PubMed ID: 28226418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria.
    Kaplan A; Ferrer M; Bernstein JA; Antonova E; Trzaskoma B; Raimundo K; Rosén K; Omachi TA; Khalil S; Zazzali JL
    J Allergy Clin Immunol; 2016 Feb; 137(2):474-81. PubMed ID: 26483177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on Omalizumab for Urticaria: What's New in the Literature from Mechanisms to Clinic.
    Larenas-Linnemann DES; Parisi CAS; Ritchie C; Cardona-Villa R; Cherrez-Ojeda I; Cherrez A; Ensina LF; Garcia E; Medina IV; Rodríguez-González M; Caraballo JMS
    Curr Allergy Asthma Rep; 2018 May; 18(5):33. PubMed ID: 29744661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omalizumab in Chronic Spontaneous Urticaria: A Brazilian Real-Life Experience.
    Ensina LF; Valle SO; Juliani AP; Galeane M; Vieira dos Santos R; Arruda LK; Melo JM; de Souza PK; Serpa FS; de Andrade DM; França AT; Campos RA; Camelo-Nunes I; Solé D
    Int Arch Allergy Immunol; 2016; 169(2):121-4. PubMed ID: 27055122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of aquagenic urticaria successfully treated with omalizumab.
    Rorie A; Gierer S
    J Allergy Clin Immunol Pract; 2016; 4(3):547-8. PubMed ID: 26852068
    [No Abstract]   [Full Text] [Related]  

  • 16. A Case of Hypocomplementemic Urticarial Vasculitis Syndrome Successfully Treated With Omalizumab.
    Nucera E; Basta F; Buonomo A; Mezzacappa S; Margiotta DP; Antonelli Incalzi R; Schiavino D
    J Investig Allergol Clin Immunol; 2017; 27(6):382-384. PubMed ID: 29199964
    [No Abstract]   [Full Text] [Related]  

  • 17. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria.
    Saini S; Rosen KE; Hsieh HJ; Wong DA; Conner E; Kaplan A; Spector S; Maurer M
    J Allergy Clin Immunol; 2011 Sep; 128(3):567-73.e1. PubMed ID: 21762974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solar urticaria.
    Goetze S; Elsner P
    J Dtsch Dermatol Ges; 2015 Dec; 13(12):1250-3. PubMed ID: 26612794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retreatment with omalizumab results in rapid remission in chronic spontaneous and inducible urticaria.
    Metz M; Ohanyan T; Church MK; Maurer M
    JAMA Dermatol; 2014 Mar; 150(3):288-90. PubMed ID: 24477320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of omalizumab (Xolair®) in the treatment of a case of solar urticaria caused by ultraviolet A and visible light.
    Duchini G; Bäumler W; Bircher AJ; Scherer K
    Photodermatol Photoimmunol Photomed; 2011 Dec; 27(6):336-7. PubMed ID: 22092741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.